Lannett Strikes Deal For Respirent’s US Advair Rival

 
• By Dave Wallace

Lannett has struck a deal giving it exclusive US distribution rights for 10 years to a generic version of Advair Diskus being developed by China’s Respirent.

Fresh air
Lannett Has Gained Distribution Rights To The Respiratory Candidate • Source: Shutterstock

More from Deals

More from Business